| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |